drugset / Trial / NCT02526888
Pharmacokinetic Interaction Between Diltiazem and ACT-541468 in Healthy Subjects
RandomizedCrossoverOpen-labelOther
Summary
The main objective of this study is to investigate whether repeated administration of a cardiac medication (diltiazem) can affect the pharmacokinetics (i.e., amount and time of presence in the blood) of ACT-541468
Timeline
- Start
- 2015-09-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daridorexant | Small molecule | 25 mg | Oral |
| Subject | Diltiazem | Small molecule | 240 mg | Oral |
Indications
No indication recorded.